Intervention

Triptorelin Pamoate

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions6

Lead sponsors shown3

Clinical trials

3 shown

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPNCT03899077 · 2019-04-05

High-Dose Brachytherapy in Treating Patients With Prostate CancerNCT02346253 · 2015-01-13

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate CancerNCT02168062 · 2014-06-16

Common conditions

Prostate Adenocarcinoma2 Cancer of Prostate1 Stage I Prostate Cancer1 Stage IIA Prostate Cancer1 Stage IIB Prostate Cancer1 Stage III Prostate Cancer1

Leading sponsors

Cancer Research Antwerp1 Stanford University1 University of California, San Francisco1

Trial status mix

COMPLETED1

TERMINATED1

UNKNOWN1

Phase mix

PHASE22

NA1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.